Ispecimen Stock Performance
| ISPC Stock | USD 0.33 0.03 8.61% |
The company retains a Market Volatility (i.e., Beta) of 3.84, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ISpecimen will likely underperform. At this point, iSpecimen has a negative expected return of -1.09%. Please make sure to check out ISpecimen's potential upside, as well as the relationship between the day median price and relative strength index , to decide if iSpecimen performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days iSpecimen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Last Split Factor 1:20 | Last Split Date 2024-09-16 |
1 | iSpecimen Approves Key Proposals in Stockholder Meeting - TipRanks | 11/03/2025 |
2 | iSpecimen Faces Nasdaq Delisting Notice for Stock Price - TipRanks | 11/21/2025 |
3 | iSpecimen Regains Nasdaq Compliance as of November 2025 - TipRanks | 12/01/2025 |
4 | Would You Still Hold iSpecimen Stock If It Fell Another 30 - Trefis | 12/05/2025 |
5 | 12 Health Care Stocks Moving In Wednesdays Pre-Market Session | 12/31/2025 |
6 | E.F. Hutton Co. Acts as Exclusive Placement Agent in iSpecimen Inc.s 5.5 Million Private Placement | 01/06/2026 |
7 | Disposition of 18229 shares by Ianelli Christopher of ISpecimen subject to Rule 16b-3 | 01/28/2026 |
| Begin Period Cash Flow | 2.3 M | |
| Total Cashflows From Investing Activities | 2 M | |
| Free Cash Flow | -8.3 M |
ISpecimen | Build AI portfolio with ISpecimen Stock |
ISpecimen Relative Risk vs. Return Landscape
If you would invest 78.00 in iSpecimen on October 31, 2025 and sell it today you would lose (44.78) from holding iSpecimen or give up 57.41% of portfolio value over 90 days. iSpecimen is currently does not generate positive expected returns and assumes 7.9647% risk (volatility on return distribution) over the 90 days horizon. In different words, 71% of stocks are less volatile than ISpecimen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ISpecimen Target Price Odds to finish over Current Price
The tendency of ISpecimen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.33 | 90 days | 0.33 | about 82.57 |
Based on a normal probability distribution, the odds of ISpecimen to move above the current price in 90 days from now is about 82.57 (This iSpecimen probability density function shows the probability of ISpecimen Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.84 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ISpecimen will likely underperform. Additionally ISpecimen has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ISpecimen Price Density |
| Price |
Predictive Modules for ISpecimen
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as iSpecimen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ISpecimen Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ISpecimen is not an exception. The market had few large corrections towards the ISpecimen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold iSpecimen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ISpecimen within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.12 | |
β | Beta against Dow Jones | 3.84 | |
σ | Overall volatility | 0.16 | |
Ir | Information ratio | -0.12 |
ISpecimen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ISpecimen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for iSpecimen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| iSpecimen generated a negative expected return over the last 90 days | |
| iSpecimen has high historical volatility and very poor performance | |
| iSpecimen has some characteristics of a very speculative penny stock | |
| iSpecimen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 9.29 M. Net Loss for the year was (12.5 M) with profit before overhead, payroll, taxes, and interest of 722.54 K. | |
| iSpecimen currently holds about 23.69 M in cash with (8.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.67, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| iSpecimen has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Disposition of 18229 shares by Ianelli Christopher of ISpecimen subject to Rule 16b-3 |
ISpecimen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ISpecimen Stock often depends not only on the future outlook of the current and potential ISpecimen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ISpecimen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 710.9 K | |
| Cash And Short Term Investments | 1.9 M |
ISpecimen Fundamentals Growth
ISpecimen Stock prices reflect investors' perceptions of the future prospects and financial health of ISpecimen, and ISpecimen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ISpecimen Stock performance.
| Return On Equity | -2.96 | ||||
| Return On Asset | -0.75 | ||||
| Operating Margin | (26.55) % | ||||
| Current Valuation | 792.5 K | ||||
| Shares Outstanding | 9.77 M | ||||
| Price To Earning | 0.78 X | ||||
| Price To Book | 1.07 X | ||||
| Price To Sales | 1.01 X | ||||
| Revenue | 9.29 M | ||||
| Gross Profit | 722.54 K | ||||
| EBITDA | (12.73 M) | ||||
| Net Income | (12.5 M) | ||||
| Cash And Equivalents | 23.69 M | ||||
| Cash Per Share | 2.67 X | ||||
| Total Debt | 312.17 K | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 13.37 X | ||||
| Book Value Per Share | 0.31 X | ||||
| Cash Flow From Operations | (8.26 M) | ||||
| Earnings Per Share | (7.82) X | ||||
| Market Capitalization | 3.38 M | ||||
| Total Asset | 9.35 M | ||||
| Retained Earnings | (71.86 M) | ||||
| Working Capital | (2.18 M) | ||||
About ISpecimen Performance
By analyzing ISpecimen's fundamental ratios, stakeholders can gain valuable insights into ISpecimen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ISpecimen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ISpecimen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 8.48 | 6.69 | |
| Return On Tangible Assets | (3.57) | (3.40) | |
| Return On Capital Employed | (4.09) | (3.88) | |
| Return On Assets | (1.20) | (1.26) | |
| Return On Equity | (4.34) | (4.12) |
Things to note about iSpecimen performance evaluation
Checking the ongoing alerts about ISpecimen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for iSpecimen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| iSpecimen generated a negative expected return over the last 90 days | |
| iSpecimen has high historical volatility and very poor performance | |
| iSpecimen has some characteristics of a very speculative penny stock | |
| iSpecimen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 9.29 M. Net Loss for the year was (12.5 M) with profit before overhead, payroll, taxes, and interest of 722.54 K. | |
| iSpecimen currently holds about 23.69 M in cash with (8.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.67, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| iSpecimen has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Disposition of 18229 shares by Ianelli Christopher of ISpecimen subject to Rule 16b-3 |
- Analyzing ISpecimen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ISpecimen's stock is overvalued or undervalued compared to its peers.
- Examining ISpecimen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ISpecimen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ISpecimen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ISpecimen's stock. These opinions can provide insight into ISpecimen's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ISpecimen Stock analysis
When running ISpecimen's price analysis, check to measure ISpecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISpecimen is operating at the current time. Most of ISpecimen's value examination focuses on studying past and present price action to predict the probability of ISpecimen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISpecimen's price. Additionally, you may evaluate how the addition of ISpecimen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |